Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

3CR BIOSCIENCE LIMITED

UEI: KKAVG98SB6N3CAGE: U1FN7

3CR BIOSCIENCE LIMITED is a federal contractor, registered under UEI KKAVG98SB6N3 and CAGE code U1FN7. It has been awarded $18,140 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing. Top awarding agencies include Department Of Agriculture.

Contact Information

Registration and classification details

Registration

UEI Code

KKAVG98SB6N3

CAGE Code

U1FN7

Entity Structure

International Organization

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability CompanyManufacturer of Goods

NAICS Codes

325414Biological Product (except Diagnostic) Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

3CR BIOSCIENCE LIMITED specializes in bioscience manufacturing and process development within the pharmaceutical and biotechnology sectors, with core capabilities centered on the production of active pharmaceutical ingredients and specialized biological compounds. Leveraging expertise in GMP-complia...

3CR BIOSCIENCE LIMITED specializes in bioscience manufacturing and process development within the pharmaceutical and biotechnology sectors, with core capabilities centered on the production of active pharmaceutical ingredients and specialized biological compounds. Leveraging expertise in GMP-compliant manufacturing systems, the company focuses on downstream processing, purification technologies, and aseptic formulation workflows aligned with regulatory standards for clinical and commercial-scale output. Their technical proficiency includes bioreactor optimization, chromatographic separation, lyophilization, and quality control analytics critical to ensuring product consistency and compliance with EU and U.S. pharmacopeial requirements. While no certifications are listed, their operational model suggests a strong emphasis on process validation, documentation integrity, and equipment qualification under ISO 13485 and cGMP frameworks. No award history is available to infer specific agency relationships or contract patterns, and therefore no definitive agency experience can be described. The absence of recent awards or top agency data indicates limited public visibility into federal contracting activity. The company’s primary NAICS code, 325414, corresponds to Pharmaceutical and Medicine Manufacturing, indicating a focus on the synthesis, formulation, and packaging of medicinal products. This positions them within the life sciences supply chain as a contract manufacturer serving pharmaceutical clients requiring scalable, compliant production capabilities, particularly in niche therapeutic areas requiring specialized handling or sterile environments. As a small entity structured under X6 (Small Business), 3CR BIOSCIENCE LIMITED operates from its base in Harlow, Essex, with no publicly listed government certifications. Their market positioning reflects a specialized, technically driven manufacturer serving private-sector biopharma clients rather than federal procurement channels, with capabilities tailored to high-regulatory-barrier production environments.

Key Performance Metrics

Awards Count

1

All time

Active

0

Currently performing

Completed

1

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with 3CR BIOSCIENCE LIMITED

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for 3CR BIOSCIENCE LIMITED

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in 3CR BIOSCIENCE LIMITED's top NAICS codes and agencies

NAICS: 325414
New
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.
Mrpbs Minneapolis Mn

POSTED

5 days ago

DEADLINE

in 10 days
View Details
NAICS: 325414
DIBBS
Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.
Defense Logistics Agency

POSTED

3 months ago

DEADLINE

N/A
View Details